Overview

Precision Functional Brain Mapping in Psilocybin

Status:
Recruiting

Trial end date:
2022-02-28

Target enrollment:

Participant gender:

Summary

This project will employ functional brain imaging to study the mechanism and immediate and long-term effects of psilocybin, a serotonin receptor 2A agonist, on cortical and cortico-subcortical brain networks in healthy adults.

Phase:

Early Phase 1

Details

Lead Sponsor:

Washington University School of Medicine

Treatments:

Methylphenidate
Psilocin
Psilocybin